Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.4% of adults in Grand Rapids have diagnosed diabetes — 1.6 points below the U.S. 12% figure. Census population 198,917. Michigan Medicare wound biologics: WPS Government Health Administrators (J8). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Grand Rapids clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Grand Rapids storefront.
Growth Factor Therapy for Tissue Repair in Grand Rapids, MI for clinics & physicians. Growth factor therap… Compliance support & pricing — contact Hawk Medical.
Grand Rapids is a city under 250k (198,917 Census). CDC PLACES (2023, crude) estimates 10.4% of adults in Grand Rapids have diagnosed diabetes — 1.6 points below the U.S. 12% figure. Adult arthritis here is 22.6% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)CDC PLACES (2023, crude) estimates 10.4% of adults in Grand Rapids have diagnosed diabetes — 1.6 points below the U.S. 12% figure. Adult obesity in Grand Rapids is 36.4% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 22.6% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: J8 / WPS Government Health Administrators, sibling states IN. Michigan Department of Health & Human Services is the public-health home. We will not mash those grains into a fake “demand score.”
Vendor consolidation is boring on purpose: one account, IFUs filed, J8 articles mapped. 9.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 10.4% of adults — 1.6 points below the U.S. 12% figure. Obesity is 36.4%; arthritis is 22.6%. That is place-level BRFSS modeling, not a clinic census and not a Grand Rapids trial.
We do not publish a consumer directory of every account. Patients should ask their current specialist whether the practice offers growth factor therapy for tissue repair and which products they use.
No. Organization schema on this site does not publish a fake aggregateRating. Testimonials on marketing pages are not assigned to Grand Rapids as local reviews.
No. Hawk Medical LLC is a national distributor founded in 2014. We ship HCT/P 361-compliant tissue, PRP systems, and wound-care biologics to physician practices nationwide, including Michigan. There is no Grand Rapids storefront or local street address on this page because we are a service-area distributor, not a walk-in clinic.
If you operate in Michigan and another MAC state, say it on the first call. J8 will not port 1:1. We would rather split utilization than watch a sister clinic copy Grand Rapids tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Grand Rapids, MI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Grand Rapids is J8 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Grand Rapids — 1.6 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Michigan Part B wound biologics follow this contractor (siblings: IN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Grand Rapids. Useful for joint-program math; still needs a diagnosis and privileging.
No Grand Rapids storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.